Polypeptide-Based Systems: From Synthesis to Application in Drug Delivery

Synthetic polypeptides are biocompatible and biodegradable macromolecules whose composition and architecture can vary over a wide range. Their unique ability to form secondary structures, as well as different pathways of modification and biofunctionalization due to the diversity of amino acids, prov...

Full description

Saved in:
Bibliographic Details
Main Authors: Mariia Stepanova (Author), Alexey Nikiforov (Author), Tatiana Tennikova (Author), Evgenia Korzhikova-Vlakh (Author)
Format: Book
Published: MDPI AG, 2023-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_3187d97a07c64a73b0b54a57e741fe33
042 |a dc 
100 1 0 |a Mariia Stepanova  |e author 
700 1 0 |a Alexey Nikiforov  |e author 
700 1 0 |a Tatiana Tennikova  |e author 
700 1 0 |a Evgenia Korzhikova-Vlakh  |e author 
245 0 0 |a Polypeptide-Based Systems: From Synthesis to Application in Drug Delivery 
260 |b MDPI AG,   |c 2023-11-01T00:00:00Z. 
500 |a 10.3390/pharmaceutics15112641 
500 |a 1999-4923 
520 |a Synthetic polypeptides are biocompatible and biodegradable macromolecules whose composition and architecture can vary over a wide range. Their unique ability to form secondary structures, as well as different pathways of modification and biofunctionalization due to the diversity of amino acids, provide variation in the physicochemical and biological properties of polypeptide-containing materials. In this review article, we summarize the advances in the synthesis of polypeptides and their copolymers and the application of these systems for drug delivery in the form of (nano)particles or hydrogels. The issues, such as the diversity of polypeptide-containing (nano)particle types, the methods for their preparation and drug loading, as well as the influence of physicochemical characteristics on stability, degradability, cellular uptake, cytotoxicity, hemolysis, and immunogenicity of polypeptide-containing nanoparticles and their drug formulations, are comprehensively discussed. Finally, recent advances in the development of certain drug nanoformulations for peptides, proteins, gene delivery, cancer therapy, and antimicrobial and anti-inflammatory systems are summarized. 
546 |a EN 
690 |a polypeptides 
690 |a polypeptide copolymers 
690 |a polypeptide particles 
690 |a self-assembly 
690 |a hydrogels 
690 |a drug delivery systems 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 15, Iss 11, p 2641 (2023) 
787 0 |n https://www.mdpi.com/1999-4923/15/11/2641 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/3187d97a07c64a73b0b54a57e741fe33  |z Connect to this object online.